D. Munz et al. / Journal of Organometallic Chemistry xxx (2015) 1e6
5
72 h in an ACE pressure tube, during which a second phase formed.
Volatiles were removed in vacuo and the residue was dissolved in
acetonitrile. The product was precipitated by addition of diethyl
ether, washed with 2 mL of THF and dried in vacuo to afford the
very hygroscopic, colorless product (2.27 g, 93%). M.p. 103 ꢁC. 1H
with 1 mL of water. The crude product was further purified by
fractionate precipitation: The organic phase was reduced to 4 mL
and 10 mL of diethyl ether were added, upon which a brown pre-
cipitate formed. Solids were rapidly filtered off, and the solvent was
removed in vacuo. Subsequently it was again dissolved in 4 mL of
dichloromethane,10 mL of diethyl ether were added and the yellow
precipitate, which formed, was again filtered off. The solution was
layered with further 30 mL of diethyl ether and stored at 3 ꢁC. After
one week 160 mg (50%) of colorless, hygroscopic crystals had
formed, which were collected and dried in vacuo. M.p. 78 ꢁC. 1H
NMR (300 MHz, DMSO-d6):
d
¼ 9.43 (s, 2H, NCHN), 8.00 (s, 2H,
NCH), 7.86 (s, 2H, NCH), 6.68 (s, 2H, CH2), 4.42 (t, J ¼ 4.7 Hz, 4H,
CH2), 3.79 (t, 4.8 Hz, 4H, CH2), 3.60e3.35 (m, 16H, CH2), 3.24 (s, 6H,
CH3) ppm. 13C NMR NMR (151 MHz, DMSO-d6):
d
¼ 137.8 (CH),
123.6 (CH), 121.8 (CH), 71.2 (CH2), 69.5 (CH2), 69.5 (CH2), 69.4
(CH2), 67.81 (CH2), 58.1 (CH3), 57.8 (CH2), 49.2 (CH2) ppm. Anal.
Calcd. for C21H38Br2N4O6 (602.36): C 41.87, H 6.36, N 9.30% found C
41.86, H 6.59, N 9.41%.
NMR (300 MHz, CDCl3):
d
¼ 7.87 (s, 2H, CH), 7.57 (d, 2H, J ¼ 1.9 Hz,
NCH), 7.15 (d, 2H, J ¼ 1.9 Hz, NCH), 4.93 (m, 2H, CH2), 4.65 (m, 2H,
CH2), 4.07 (m, 2H, CH2), 3.87 (m, 2H, CH2), 3.64 (s, 8H, CH2), 3.62 (m,
4H, CH2), 3.56 (m, 4H, CH2), 3.38 (s, 6H, CH3) ppm. 13C NMR
3,30-Bis{1,10-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-[4,5-dibromo-
(1,10-diimidazolium)}-1,2-phenylene]-dibromide (4)
(75 MHz, CDCl3):
(Cipso), 125.1 (CH), 121.9 (CH), 71.9 (CH2), 70.3 (CH2), 70.3(CH2), 70.1
(CH2), 70.1 (CH2), 59.0 (CH3), 51.6 (CH2) ppm. Anal. Calcd. for
d
¼ 164.0 (NCN), 132.6 (Cipso), 131.3 (CH), 126.3
0.23 g (0.63 mmol) of the dibromo phenylene bridged bisimi-
dazol 2 was stirred with 0.31 g (1.37 mmol) of 1-[2-bromoethoxy-
C
26H36N4Br4O6Pd (926.62): C 33.70, H 3.92, N 6.05% found C 34.02,
(2-methoxyethoxy)ethoxy]ethane in 5 mL of acetonitrile at 120 ꢁ
C
H 3.97, N 6.19%. ESI-MS: m/z ¼ 847.0 [PdL$Br]þ.
for 72 h in an ACE pressure tube. The product was precipitated by
addition of 50 mL of diethyl ether at 3 ꢁC, washed with 5 mL ethyl
acetate and dried in vacuo to afford the very hygroscopic, colorless
product (0.35 g, 68%). M.p. 60 ꢁC. 1H NMR (300 MHz, DMSO-d6):
3,30-Bis{1,10-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-(1,10-
diimidazoline-2,20-diylidene)}-methylene-platinum(II)dibromide(7)
0.29 g (0.75 mmol) of platinum(II) acetylacetonate was stirred
with 0.45 g (0.75 mmol) of the bisimidazolium salt 3 in 10 mL of
DMSO for 3 h at 60 ꢁC, 3 h at 80 ꢁC and 3 h at 110 ꢁC. The solvent was
removed in vacuo at 60 ꢁC, the residue was dissolved in 5 mL of
dichloromethane and washed with 3 mL of water. The crude
product was further purified by fractionate precipitation: Diethyl
ether was added to the organic phase, until a brown precipitate
formed. Solids were rapidly filtered off, and the solution was
layered with further 50 mL of diethyl ether and stored at 3 ꢁC. After
one week 0.34 g (58%) of colorless, hygroscopic crystals had formed,
which were collected and dried in vacuo.
d
¼ 9.54 (s, 2H, NCHN), 8.52 (s, 2H, CH), 7,90 (s, 2H, CH), 7.75 (s, 2H,
CH), 4.43 (t, 4H, J ¼ 4.5 Hz, CH2), 3.81 (t, 4H, J ¼ 4.5 Hz, CH2), 3.57 (m,
4H, CH2), 3.51 (m, 8H, CH2), 3.40 (m, 4H, CH2), 3.20 (s, 6H, CH3) ppm.
13C NMR (75 MHz, DMSO-d6):
d
¼ 138.4 (NCHN), 132.6 (CH), 129.8
(Cipso), 127.2 (Cipso), 123.7 (CH), 122.7 (CH), 71.2 (CH2), 69.6 (CH2),
69.5(CH2), 67.9 (CH2), 67.0 (CH2), 58.1 (CH3), 49.4 (CH2) ppm. Anal.
Calcd. for C26H38N4O6Br4 (822.22): C 37.98, H 4.66, N 6.81% found C
37.54, H 4.40, N 6.68%.
Synthesis of the bis-NHC complexes
M.p. 78 ꢁC. 1H NMR (500 MHz, CDCl3):
NCH), 7.24 (d, J ¼ 1.9 Hz, 2H, NCH), 6.10 (dd, J ¼ 12.9 Hz, J ¼ 105.6 Hz
2H, CH2), 4.75e4.50 (m, 4H, CH2), 4.0e3.7 (m, 4H, CH2), 3.7e3.65
(m, 16H, CH2), 3.46 (s, 6H, CH3) ppm. 13C NMR (126 MHz, CDCl3):
d
¼ 7.31 (d, J ¼ 1.9 Hz, 2H,
3,30-Bis{1,10-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-(1,10-
diimidazoline-2,20-diylidene)}-methylene-palladium(II)dibromide (5)
0.45 g (2.0 mmol) of palladium acetate was stirred with 1.20 g
(2.0 mmol) of the bisimidazolium salt 3 in 15 mL of DMSO for 2 h at
40 ꢁC, 2 h at 60 ꢁC, 2 h 80 ꢁC, 2 h at 100 ꢁC and 2 h at 120 ꢁC. The
solvent was removed in vacuo at 60 ꢁC, the residue was dissolved in
4 mL of dichloromethane and it was washed with 5 mL of water.
The organic layer was dried with Na2SO4, reduced to 3 mL, and the
crude product was precipitated by addition of 40 mL of diethyl
ether at 3 ꢁC. After filtration, the solid was dissolved in 3 mL of
dichloromethane, layered with 40 mL of diethyl ether and stored at
3 ꢁC. After three days 1.34 g (95%) of colorless, hygroscopic crystals
had formed, which were collected and dried in vacuo. M.p. 81 ꢁC. 1H
d
¼ 145.1 (NCN), 122.5 (CH), 119.9 (CH), 71.9 (CH2), 70.8 (CH2), 70.4
(CH3), 70.3 (CH3), 70.1 (CH3), 60.4 (CH2), 59.1 (CH3), 50.6 (CH2) ppm.
ESI-MS: m/z ¼ 715.1 [PtL$Br]þ. Anal. Calcd. for C21H36Br2N4O6Pt
(795.43): C 31.71, H 4.56, N 7.04% found C 31.60, H 4.29, N 7.01%.
3,30-Bis{1,10-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-[4,5-dibromo-
(1,10-diimidazoline-2,20-diylidene)}-1,2-phenylene]platinum(II)
dibromide (8)
0.12 g (0.31 mmol) of platinum(II) acetylacetonate was stirred
with 250 mg (0.30 mmol) of the bisimidazolium salt 4 in 8 mL of
DMSO for 2 h at 40 ꢁC, 2 h at 60 ꢁC, 2 h at 80 ꢁC, 2 h at 80 ꢁC and
3.5 h at 120 ꢁC. The solvent was removed in vacuo at 60 ꢁC, the
residue was dissolved in 5 mL of THF and solids were filtered off.
The THF was removed under reduced pressure and the crude
product was further purified by fractionate precipitation: The
residue was dissolved in 3 mL of dichloromethane and diethyl
ether was added until the precipitation of a brown solid. The so-
lution was filtered off and the solvent was removed in vacuo. The
residue was dissolved in 3 mL of dichloromethane and precipitated
with diethyl ether. 0.09 g (29%) of a light brown solid was collected
and dried in vacuo.
NMR (500 MHz, CDCl3):
d
¼ 7.48 (d, J ¼ 1.9 Hz, 2H, NCH), 7.24 (d,
J ¼ 1.9 Hz, 2H, NCH), 6.39 (dd, J ¼ 13.24 Hz, J ¼ 17.02 Hz, 2H, CH2),
4.7e4.6 (m, 4H, CH2), 4.7e3.7 (m, 4H, CH2), 3.50e3.65 (m,16H, CH2),
3.37 (s, 6H, CH3) ppm. 13C NMR (126 MHz, CDCl3):
d
¼ 159.3 (NCN),
123.0 (CH), 121.2 (CH), 71.9 (CH2), 70.9 (CH2), 70.4 (CH2) 70.3 (CH2),
70.2 (CH2), 64.0 (CH2), 59.1 (CH3), 51.4 (CH2) ppm. Anal Calcd. for
C
21H36Br2N4O6Pd (706.76): C 35.69, H 5.13, N 7.93% found 35.77, H
5.08, N 8.04%. ESI-MS: m/z ¼ 627.1 [PdL$Br]þ.
3,30-Bis{1,10-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}-[4,5-dibromo-
(1,10-diimidazoline-2,20-diylidene)}-1,2-phenylene]palladium(II)
dibromide (6)
94 mg (0.35 mmol) of palladium acetate was stirred with
250 mg (0.30 mmol) of the bisimidazolium salt 4 in 8 mL of DMSO
for 12 h at 40 ꢁC and 1 h at 60 ꢁC. The solvent was removed in vacuo
at 60 ꢁC, the residue was dissolved in 5 mL of THF and solids were
filtered off. The THF was removed under reduced pressure, the
residue was dissolved in 10 mL of dichloromethane and washed
M.p. 121 ꢁC. 1H NMR (300 MHz, CDCl3):
d
¼ 7.81 (s, 2H, CH), 7.54
(d, 2H, J ¼ 2.1 Hz, NCH), 7.07 (d, 2H, J ¼ 2.3 Hz, NCH), 4.89 (m, 2H,
CH2), 4.62 (m, 2H, CH2), 4.04 (m, 2H, CH2), 3.86 (m, 2H, CH2),
3.68e3.60 (m, 12H, CH2), 3.59e3.50 (m, 4H, CH2), 3.38 (s, 6H, CH3)
ppm. 13C NMR (75 MHz, CDCl3):
(CH), 126.0 (Cipso), 124.3 (CH), 120.8 (CH), 71.9 (CH2), 70.34 (CH2),
d
¼ 152.1 (NCN), 133.3 (Cipso), 131.0
70.30 (CH2), 70.13 (CH2), 70.10 (CH2), 59.0 (CH3), 50.9 (CH2) ppm.
j.jorganchem.2015.03.027